Kura Oncology (KURA) Change in Cash (2010 - 2026)

Kura Oncology (KURA) reported Change in Cash of -$110.0 million for Q1 2026, up 36.48% year-over-year from -$80.6 million in Q1 2025, and down 304.45% on a QoQ basis from $53.8 million in Q4 2025.

Kura Oncology (KURA) has 17 years of Change in Cash data on file, last reported at -$110.0 million in Q1 2026.

  • Quarterly Change in Cash rose 36.48% year-over-year to -$110.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.2 million (down 224.82% YoY) and the FY2025 annual result came in at -$75.4 million, down 140.27% from the prior year.
  • Change in Cash fell to -$110.0 million in Q1 2026 per KURA's latest filing, from $53.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $175.0 million in Q4 2024 and bottomed at -$173.2 million in Q1 2025.
  • The 5-year median for Change in Cash is $4.3 million (2024), against an average of -$3.0 million.
  • The widest annual swing landed in 2022, when Change in Cash soared 24627.27%; it then sank 4235.46% in 2025.
  • Tracing KURA's Change in Cash over 5 years: stood at -$39.1 million in 2022, then soared by 121.92% to $8.6 million in 2023, then surged by 1939.89% to $175.0 million in 2024, then plunged by 69.25% to $53.8 million in 2025, then plunged by 304.45% to -$110.0 million in 2026.
  • Per Business Quant, the three latest KURA Change in Cash figures stand at -$110.0 million (Q1 2026), $53.8 million (Q4 2025), and $13.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.44 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 623.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 417.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -153.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.61 Mn
10 Kura Oncology 801.92 Mn 801.92 Mn 18.00 Mn -110.02 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -110.02 Mn
Dec 31, 2025 53.81 Mn
Sep 30, 2025 13.34 Mn
Jun 30, 2025 30.68 Mn
Mar 31, 2025 -173.19 Mn
Dec 31, 2024 174.98 Mn
Sep 30, 2024 4.30 Mn
Jun 30, 2024 3.68 Mn
Mar 31, 2024 4.19 Mn
Dec 31, 2023 8.58 Mn
Sep 30, 2023 -20.38 Mn
Jun 30, 2023 22.07 Mn
Mar 31, 2023 -24.74 Mn
Dec 31, 2022 -39.14 Mn
Sep 30, 2022 51.68 Mn
Jun 30, 2022 5.43 Mn
Mar 31, 2022 -56.84 Mn
Dec 31, 2021 51.49 Mn
Sep 30, 2021 209,000.00
Jun 30, 2021 -71.86 Mn
Mar 31, 2021 -214.66 Mn
Dec 31, 2020 248.54 Mn
Sep 30, 2020 -57.80 Mn
Jun 30, 2020 100.95 Mn
Mar 31, 2020 7.89 Mn
Dec 31, 2019 -28.61 Mn
Sep 30, 2019 -67.34 Mn
Jun 30, 2019 104.30 Mn
Mar 31, 2019 1.66 Mn
Dec 31, 2018 -4.45 Mn
Sep 30, 2018 2.91 Mn
Jun 30, 2018 -8.86 Mn
Mar 31, 2018 15.09 Mn
Dec 31, 2017 -11.90 Mn
Sep 30, 2017 11.18 Mn
Jun 30, 2017 1.51 Mn
Mar 31, 2017 917,000.00
Dec 31, 2016 2.94 Mn
Sep 30, 2016 -5.33 Mn
Jun 30, 2016 -4.21 Mn
Mar 31, 2016 883,000.00
Dec 31, 2015 4.23 Mn
Sep 30, 2015 -8.57 Mn
Jun 30, 2015 -33.78 Mn
Mar 31, 2015 52.45 Mn
Dec 31, 2014 1.12 Mn
Sep 30, 2014 82,000.00
Jun 30, 2014 -1,250.00
Mar 31, 2014 -400.00
Dec 31, 2013 -4,012.00
Sep 30, 2013 -8,125.00
Jun 30, 2013 15,804.00
Mar 31, 2013 -1,901.00
Dec 31, 2012 -784.00
Sep 30, 2012 -3,895.00
Jun 30, 2012 -14,262.00
Mar 31, 2012 19,523.00
Dec 31, 2011 -1,935.00
Sep 30, 2011 -3,100.00
Jun 30, 2011 -15,379.00
Mar 31, 2011 -2,264.00
Dec 31, 2010 24,644.00
Sep 30, 2010 -3,506.00